Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD)

K-Number: K790248 · 1979-04-04

ApplicantBoehringer Laboratories
Decision Date1979-04-04
Product CodeCFJ
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD) is the device name listed in this FDA 510(k) record. The listed applicant is Boehringer Laboratories. It received FDA 510(k) clearance on 1979-04-04 under 510(k) number K790248. The device is classified under product code CFJ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD)?

NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD) is a medical device that received FDA 510(k) clearance on 1979-04-04. The listed applicant is Boehringer Laboratories. The 510(k) number is K790248.

When did NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD) receive FDA 510(k) clearance?

NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD) received FDA 510(k) clearance on 1979-04-04, under 510(k) number K790248.

Who is the listed applicant for NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD)?

The FDA 510(k) record lists Boehringer Laboratories as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD)?

The FDA product code for NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD) is CFJ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Boehringer Laboratories as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K234145ViSiGi 3D Gastric Sizing TubeK061788BOEHRINGER LABORATORIES SUCTION PUMP SYSTEMK060277BOEHRINGER LABORATORIES SUCTION PUMP SYSTEMK020538BOEHRINGER LABORATORIES PNEUMATIC AMBULATORY COMPRESSION SYSTEM 8200 SERIESK014187AUTOVAC ORTHOPEDIC AUTOTRANSFUSION SYSTEMK013976BOEHRINGER MRI SUCTION REGULATORY

View all 38 devices →

Related Devices (Code: CFJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K131975ACE DIRECT TOTAL IRON-BINDING CAPACITY (TIBC) REAGENT, ACE TOTAL IRON REAGENT, ACE LDH-L REAGENTAlfa Wassermann Diagnostic Technologies, Inc.K091544S-TEST LACTATE DEHYDROGENASE (LD), MODEL RC 0017Alfa Wassermann, Inc.K051108PICCOLO LACTATE DEPHYDROGENASE TEST SYSTEMAbaxis, Inc.K974859LACTANE DEHYDROGENASE-SL ASSAY, CATALOGUE NUMBER 327-10, 327-30Diagnostic Chemicals , Ltd.K973589LIQUID LDH-L REAGENT SETPointe Scientific, Inc.,K970684LACTATE DEHYDROGENASE (LD)Randox Laboratories, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑